Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-08-31

Clinical Trial Update: Comparison of Aripiprazole and Risperidone for the Treatment of People With First-Episode Psychosis [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing aripiprazole and risperidone for treating first-episode psychosis in schizophrenia; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ARIPIPRAZOLE (Aripiprazole)
  • RISPERIDONE (RISPERIDONE)

Snippet

Sponsor: Northwell Health | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED | Results posted: 2016-08-31